Literature DB >> 6269999

Biological activities of crystalline pertussigen from Bordetella pertussis.

J J Munoz, H Arai, R K Bergman, P L Sadowski.   

Abstract

We studied various biological activities of crystalline pertussigen and found that in mice as little as 0.5 ng of pertussigen induced hypersensitivity to histamine, 8 to 40 ng induced leukocytosis, 2 ng increased production of insulin, 0.1 ng increased production of immunoglobulin E and immunoglobulin G1 antibodies to hen egg albumin, 9.5 ng increased susceptibility to anaphylactic shock, and 0.5 ng increased the vascular permeability of striated muscle. We also found that in Lewis rats 20 ng of pertussigen promoted the induction of hyperacute experimental allergic encephalomyelitis. Pertussigen given intraperitoneally was toxic to mice at a dose of 546 ng. Treatment of pertussigen with glutaraldehyde eliminated this toxicity. Mice immunized with 1,700 ng of detoxified pertussigen were protected against intracerebral challenge with 3 x 10(4) viable Bordetella pertussis cells. When as little as 0.5 ng of pertussigen was given intravenously to mice, the increased susceptibility of the animals to histamine could still be detected 84 days later. The biological properties of crystalline pertussigen indicate its similarity to leukocytosis-promoting factor, Islet-activating protein, late-appearing toxic factor, and mouse-protective antigen of B. pertussis.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6269999      PMCID: PMC350785          DOI: 10.1128/iai.33.3.820-826.1981

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  17 in total

1.  Effect of Bordetella pertussis extract and vasoactive amines on vascular permeability.

Authors:  R K Bergman; J J Munoz
Journal:  J Allergy Clin Immunol       Date:  1975-06       Impact factor: 10.793

2.  Vascular permeability changes in the central nervous system of rats with hyperacute experimental allergic encephalomyelitis induced with the aid of a substance from Bordetella pertussis.

Authors:  R K Bergman; J J Munoz; J L Portis
Journal:  Infect Immun       Date:  1978-08       Impact factor: 3.441

3.  Some histamine sensitizing properties of soluble preparations of the histamine sensitizing factor(HSF) from Bordetella pertussis.

Authors:  J Munoz; R K Bergman
Journal:  J Immunol       Date:  1966-07       Impact factor: 5.422

4.  Cerebral vascular permeability and cellular infiltration in experimental allergic encephalomyelitis.

Authors:  S Leibowitz; L Kennedy
Journal:  Immunology       Date:  1972-05       Impact factor: 7.397

5.  On a possible new kind of toxic substance produced by Bordetella pertussis.

Authors:  M Kurokawa; S Iwasa; S Ishida
Journal:  Jpn J Med Sci Biol       Date:  1965-06

6.  Hyperacute allergic encephalomyelitis: adjuvant effect of pertussis vaccines and extracts.

Authors:  S Levine; E J Wenk; H B Devlin; R E Pieroni; L Levine
Journal:  J Immunol       Date:  1966-09       Impact factor: 5.422

7.  Crystallization of pertussigen from Bordetella pertussis.

Authors:  H Arai; J J Munoz
Journal:  Infect Immun       Date:  1981-01       Impact factor: 3.441

8.  Leukocytosis-promoting factor of Bordetella pertussis. II. Biological properties.

Authors:  Y Sato; H Arai; K Suzuki
Journal:  Infect Immun       Date:  1973-06       Impact factor: 3.441

9.  Mouse-protecting and histamine-sensitizing activities of pertussigen and fimbrial hemagglutinin from Bordetella pertussis.

Authors:  J J Munoz; H Arai; R L Cole
Journal:  Infect Immun       Date:  1981-04       Impact factor: 3.441

10.  Isolation and properties of the leukocytosis- and lymphocytosis-promoting factor of Bordetella pertussis.

Authors:  S I Morse; J H Morse
Journal:  J Exp Med       Date:  1976-06-01       Impact factor: 14.307

View more
  78 in total

1.  Booster immunization of children with an acellular pertussis vaccine enhances Th2 cytokine production and serum IgE responses against pertussis toxin but not against common allergens.

Authors:  E J Ryan; L Nilsson; N Kjellman; L Gothefors; K H Mills
Journal:  Clin Exp Immunol       Date:  2000-08       Impact factor: 4.330

2.  Suppression of serum antibody responses by pertussis toxin after respiratory tract colonization by Bordetella pertussis and identification of an immunodominant lipoprotein.

Authors:  Nicholas H Carbonetti; Galina V Artamonova; Charlotte Andreasen; Edward Dudley; R Michael Mays; Zoe E V Worthington
Journal:  Infect Immun       Date:  2004-06       Impact factor: 3.441

3.  Construction of Bordetella pertussis strains that overproduce genetically inactivated pertussis toxin.

Authors:  G R Zealey; S M Loosmore; R K Yacoob; S A Cockle; A B Herbert; L D Miller; N J Mackay; M H Klein
Journal:  Appl Environ Microbiol       Date:  1992-01       Impact factor: 4.792

4.  Cellular pertussis vaccine containing a Bordetella pertussis strain that produces a nontoxic pertussis toxin molecule.

Authors:  I Marsili; M Pizza; F Giovannoni; G Volpini; M Bartalini; R Olivieri; R Rappuoli; L Nencioni
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

5.  Analysis of bvgR expression in Bordetella pertussis.

Authors:  Tod J Merkel; Philip E Boucher; Scott Stibitz; Vanessa K Grippe
Journal:  J Bacteriol       Date:  2003-12       Impact factor: 3.490

6.  Engineering of genetically detoxified pertussis toxin analogs for development of a recombinant whooping cough vaccine.

Authors:  S M Loosmore; G R Zealey; H A Boux; S A Cockle; K Radika; R E Fahim; G J Zobrist; R K Yacoob; P C Chong; F L Yao
Journal:  Infect Immun       Date:  1990-11       Impact factor: 3.441

7.  Regulation of DTH and IgE responses by IL-4 and IFN-gamma in immunized mice given pertussis toxin.

Authors:  H H Mu; W A Sewell
Journal:  Immunology       Date:  1994-12       Impact factor: 7.397

8.  Pertussis toxin is required for pertussis vaccine encephalopathy.

Authors:  L Steinman; A Weiss; N Adelman; M Lim; R Zuniga; J Oehlert; E Hewlett; S Falkow
Journal:  Proc Natl Acad Sci U S A       Date:  1985-12       Impact factor: 11.205

9.  Histamine release from basophils in childhood: age dependency and inhibition by pertussis infection and pertussis toxin.

Authors:  M Griese; G Merkel; R Feldmann; I Bergfeld; D Reinhardt
Journal:  Eur J Pediatr       Date:  1993-07       Impact factor: 3.183

Review 10.  Toward a mechanism-based in vitro safety test for pertussis toxin.

Authors:  Stefan F C Vaessen; Martijn W P Bruysters; Rob J Vandebriel; Saertje Verkoeijen; Rogier Bos; Cyrille A M Krul; Arnoud M Akkermans
Journal:  Hum Vaccin Immunother       Date:  2014-02-19       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.